Corrigendum to: "Aptamer/doxorubicin-conjugated nanoparticles target membranous CEMIP2 in colorectal cancer" [Int. J. Biol Macromol. 245 (2023) Jun 21; 125510/Online ahead of print. PMID: 37353120; IJBIOMAC-D-23-03903R1].
Int J Biol Macromol
; 248: 125782, 2023 Sep 01.
Article
in En
| MEDLINE
| ID: mdl-37481838
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Int J Biol Macromol
Year:
2023
Document type:
Article
Affiliation country: